Translational Research Cancer Centers Consortium
Expediting Progress in Cancer Immunotherapy
TRCCC Welcomes MSU!
At the close of the 2026 annual meeting of TRCCC, Michigan State University became a TRCCC member institution. UVA CCC will be represented on the TRCCC Board of Directors by two individuals to be named.
Welcome to the TRCCC family MSU!
TRCCC Welcomes UVA!
At the close of the 2024 annual meeting of TRCCC, the University of Virginia Comprehensive Cancer Center became a TRCCC member institution.
Welcome to the TRCCC family UVA CCC!
Dr. Lotze Named JITC Editor-in-Chief!
TRCCC would like to congratulate Dr. Mike Lotze (UMPC-Hillman Cancer Center) on his appointment as the Journal for ImmunoTherapy of Cancer (JITC) Editor-in-Chief.
JITC is the official journal of the Society for Immunotherapy of Cancer (SITC).
Dr. Lotze is a founding member and former president of TRCCC as well as a fixture at each annual meeting.
Congratulations Mike!
NAM Elects Dr. Vonderheide
TRCCC would like to congratulate Dr. Robert Vonderheide (University of Pennsylvania) on his well-deserved election to the National Academy of Medicine (NAM).
Election to the NAM is one of the nation’s highest honors in the fields of health and medicine and we are delighted to acknowledge and celebrate Dr. Vonderheide's remarkable achievement.
Read more here: National Academy of Medicine elects five new members from Penn | Penn Today
